0.639
                                            Schlusskurs vom Vortag:
              $0.6025
            Offen:
              $0.61
            24-Stunden-Volumen:
                777.33K
            Relative Volume:
              0.42
            Marktkapitalisierung:
                $3.33M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-736.70K
            KGV:
              -63.90
            EPS:
                -0.01
            Netto-Cashflow:
                $-4.14M
            1W Leistung:
              -3.55%
            1M Leistung:
              -20.13%
            6M Leistung:
                -36.73%
            1J Leistung:
              -55.31%
            Xortx Therapeutics Inc Stock (XRTX) Company Profile
Firmenname
                  
                      Xortx Therapeutics Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      -
                    
                Adresse
                  
                      -
                    
                Vergleichen Sie XRTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                XRTX
                            
                             
                        Xortx Therapeutics Inc 
                           | 
                    0.639 | 3.49M | 0 | -736.70K | -4.14M | -0.01 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Xortx Therapeutics Inc Aktie (XRTX) Neueste Nachrichten
Will XORTX Therapeutics Inc. stock see insider buyingQuarterly Profit Summary & Smart Allocation Stock Reports - newser.com
What data driven models say about XORTX Therapeutics Inc.’s futureVolume Spike & Weekly High Momentum Picks - newser.com
Is XORTX Therapeutics Inc. (ANUA) stock testing key support2025 Sector Review & AI Powered Market Entry Ideas - newser.com
Chart based exit strategy for XORTX Therapeutics Inc.July 2025 Selloffs & Consistent Income Trade Ideas - newser.com
Is XORTX Therapeutics Inc. stock cheap at current valuation2025 Earnings Impact & Reliable Breakout Stock Forecasts - newser.com
Is XORTX Therapeutics Inc. trending in predictive chart modelsEarnings Summary Report & Growth Oriented Trade Recommendations - newser.com
Heatmap analysis for XORTX Therapeutics Inc. and competitorsJuly 2025 WrapUp & Free Long-Term Investment Growth Plans - newser.com
Statistical indicators supporting XORTX Therapeutics Inc.’s strengthWeekly Trend Recap & AI Based Buy and Sell Signals - newser.com
Will XORTX Therapeutics Inc. stock benefit from commodity prices2025 Fundamental Recap & Technical Buy Zone Confirmations - newser.com
Is XORTX Therapeutics Inc. (ANUA) stock attractive for growth fundsJuly 2025 Opening Moves & Short-Term High Return Ideas - newser.com
Can XORTX Therapeutics Inc. (ANUA) stock beat analyst consensusJuly 2025 Volume & Smart Allocation Stock Reports - newser.com
Published on: 2025-11-03 02:59:46 - newser.com
Is XORTX Therapeutics Inc. forming a bottoming base2025 Bull vs Bear & Reliable Price Breakout Signals - newser.com
Can XORTX Therapeutics Inc. stock sustain revenue growthProduct Launch & Safe Entry Trade Signal Reports - newser.com
Predicting XORTX Therapeutics Inc. trend using moving averagesPortfolio Update Report & Free Expert Verified Stock Movement Alerts - newser.com
Can XORTX Therapeutics Inc. stock attract ESG capital inflowsTreasury Yields & Fast Entry High Yield Stock Tips - newser.com
Is XORTX Therapeutics Inc. stock entering bullish territoryCPI Data & Free Community Supported Trade Ideas - newser.com
How to build a custom watchlist for XORTX Therapeutics Inc.Market Growth Report & Detailed Earnings Play Alerts - newser.com
How XORTX Therapeutics Inc. (ANUA) stock reacts to stronger dollarPortfolio Performance Summary & High Accuracy Buy Signal Tips - newser.com
XORTX Therapeutics Inc. (XRTX) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
XORTX Therapeutics Completes $1.1 Million Direct Offering - MSN
Will XORTX Therapeutics Inc. bounce back from current support2025 Retail Activity & Target Return Focused Stock Picks - newser.com
Will XORTX Therapeutics Inc. stock gain from government policiesMarket Performance Recap & Weekly Stock Performance Updates - newser.com
Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN
Order flow analysis tools used on XORTX Therapeutics Inc.Bull Run & Entry Point Confirmation Alerts - newser.com
Can XORTX Therapeutics Inc. stock reach $100 price targetMarket Sentiment Review & Free Safe Entry Trade Signal Reports - newser.com
Finanzdaten der Xortx Therapeutics Inc-Aktie (XRTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):